LINC02418 and colorectal carcinoma: Knockdown of LINC02418 decreased the CRC cell growth in vitro and in vivo and limited cell migration and invasion ability, indicating that LINC02418 was able to promote CRC progress and might have a vital role in regulating tumor development-associated signaling pathways.